Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind Randomized Acetazolamide Trial in Normal Pressure Hydrocephalus

NCT04975269 is registered in ClinicalTrials.gov with Uppsala University Hospital as lead sponsor.

NCT NCT04975269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04975269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind Randomized Acetazolamide Trial in Normal Pressure Hydrocephalus
Lead sponsor
Uppsala University Hospital
Phase
Phase 2
Overall status
Completed
Start date
February 17, 2022
Completion date
April 21, 2026
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic normal pressure hydrocephalus (inph)